Literature DB >> 9158765

Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.

F Biavasco1, A Miele, C Vignaroli, E Manso, R Lupidi, P E Varaldo.   

Abstract

Despite growing concern about vancomycin-resistant enterococci (VRE) as nosocomial pathogens, especially in the United States, in Italy VRE still represent an uncommon and occasional experience for most diagnostic laboratories. We report a genotypic characterization of the first reported nosocomial outbreak of VRE in Italy. Some experiments, including plasmid analysis and pulsed-field gel electrophoresis (PFGE) assays, aimed at investigating the genetic relatedness of the VRE isolates. Other experiments, based on hybridization and polymerase chain reaction (PCR) assays, aimed at characterizing the vancomycin resistance determinants. Over a 6-month period, 21 VRE, all identified as Enterococcus faecalis, were isolated from eight patients (all treated earlier with glycopeptide antibiotics) in a neurosurgical intensive care unit. All isolates had the same biochemical profile and antibiotic susceptibility pattern, including high-level resistance to aminoglycosides and vancomycin and teicoplanin MICs of 256 and 128 micrograms/ml, respectively. Three plasmids, one strongly hybridizing with a vanA probe, were detected in all but the last of the 21 VRE isolates. The last isolate of the cluster lacked the smallest of the three plasmids. Similar restriction profiles were obtained after plasmid DNA digestion with several endonucleases, with minor differences appreciated only in the first and last isolates. Analysis of genomic DNA restriction fragment patterns by PFGE confirmed that the reported cluster of VRE isolations was due to a single nosocomial strain of E. faecalis, despite some modifications in plasmid DNA at the beginning and at the end of the outbreak. Completely different PFGE patterns were yielded by vancomycin-susceptible E. faecalis strains isolated during the same period from inpatients in the same intensive care unit. Hybridization experiments with vanA and vanS-vanH probes and DNA amplification assays using 14 PCR primer pairs specific for vanA cluster genes (vanR, vanS, vanH, vanA, and vanY), orf1, orf2, vanB, and vanC showed identical organization of resistance determinants in all epidemic VRE isolates. This organization appeared to be the same as that described for Tn1546 in VanA prototype strain E. faecium BM4147.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9158765     DOI: 10.1089/mdr.1996.2.231

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.

Authors:  R J Willems; J Top; N van den Braak; A van Belkum; D J Mevius; G Hendriks; M van Santen-Verheuvel; J D van Embden
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 2.  Diversity among multidrug-resistant enterococci.

Authors:  B E Murray
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

3.  Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins.

Authors:  P R Descheemaeker; S Chapelle; L A Devriese; P Butaye; P Vandamme; H Goossens
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

4.  Presence of a vanA-carrying pheromone response plasmid (pBRG1) in a clinical isolate of Enterococcus faecium.

Authors:  Gloria Magi; Roberta Capretti; Claudia Paoletti; Marco Pietrella; Luigi Ferrante; Francesca Biavasco; Pietro Emanuele Varaldo; Bruna Facinelli
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

5.  Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources.

Authors:  N Woodford; A M Adebiyi; M F Palepou; B D Cookson
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants.

Authors:  F Biavasco; G Foglia; C Paoletti; G Zandri; G Magi; E Guaglianone; A Sundsfjord; C Pruzzo; G Donelli; B Facinelli
Journal:  Appl Environ Microbiol       Date:  2007-03-09       Impact factor: 4.792

7.  In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.

Authors:  F Biavasco; C Vignaroli; R Lupidi; E Manso; B Facinelli; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.